nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenobarbital—CYP3A4—bone cancer	0.239	1	CbGaD
Phenobarbital—CYP4A11—Cisplatin—bone cancer	0.131	0.213	CbGbCtD
Phenobarbital—ABCC3—Cisplatin—bone cancer	0.0629	0.102	CbGbCtD
Phenobarbital—ABCC1—Epirubicin—bone cancer	0.0487	0.0792	CbGbCtD
Phenobarbital—ABCC3—Doxorubicin—bone cancer	0.0421	0.0686	CbGbCtD
Phenobarbital—ABCC3—Methotrexate—bone cancer	0.0408	0.0664	CbGbCtD
Phenobarbital—ABCB11—Doxorubicin—bone cancer	0.0364	0.0593	CbGbCtD
Phenobarbital—CYP1B1—Doxorubicin—bone cancer	0.0364	0.0593	CbGbCtD
Phenobarbital—ABCC2—Carboplatin—bone cancer	0.0334	0.0544	CbGbCtD
Phenobarbital—ABCC2—Cisplatin—bone cancer	0.0286	0.0465	CbGbCtD
Phenobarbital—ABCC1—Doxorubicin—bone cancer	0.0259	0.0421	CbGbCtD
Phenobarbital—ABCC1—Methotrexate—bone cancer	0.0251	0.0408	CbGbCtD
Phenobarbital—ABCC2—Doxorubicin—bone cancer	0.0192	0.0312	CbGbCtD
Phenobarbital—ABCC2—Methotrexate—bone cancer	0.0186	0.0302	CbGbCtD
Phenobarbital—CYP2B6—Cisplatin—bone cancer	0.0182	0.0296	CbGbCtD
Phenobarbital—CYP2B6—Doxorubicin—bone cancer	0.0122	0.0198	CbGbCtD
Phenobarbital—CYP2C9—Cisplatin—bone cancer	0.0096	0.0156	CbGbCtD
Phenobarbital—ABCB1—Cisplatin—bone cancer	0.00932	0.0152	CbGbCtD
Phenobarbital—ABCB1—Doxorubicin—bone cancer	0.00624	0.0102	CbGbCtD
Phenobarbital—ABCB1—Methotrexate—bone cancer	0.00605	0.00984	CbGbCtD
Phenobarbital—CYP3A4—Doxorubicin—bone cancer	0.00374	0.00609	CbGbCtD
Phenobarbital—Extravasation—Carboplatin—bone cancer	0.00267	0.0607	CcSEcCtD
Phenobarbital—Anaemia megaloblastic—Methotrexate—bone cancer	0.00159	0.0362	CcSEcCtD
Phenobarbital—Necrosis—Cisplatin—bone cancer	0.000872	0.0198	CcSEcCtD
Phenobarbital—Liver injury—Cisplatin—bone cancer	0.000813	0.0185	CcSEcCtD
Phenobarbital—Extravasation—Cisplatin—bone cancer	0.000784	0.0178	CcSEcCtD
Phenobarbital—Pain—Carboplatin—bone cancer	0.000712	0.0162	CcSEcCtD
Phenobarbital—Hepatocellular injury—Cisplatin—bone cancer	0.000684	0.0155	CcSEcCtD
Phenobarbital—Body temperature increased—Carboplatin—bone cancer	0.000658	0.0149	CcSEcCtD
Phenobarbital—Body temperature decreased—Epirubicin—bone cancer	0.000627	0.0142	CcSEcCtD
Phenobarbital—Hypothermia—Epirubicin—bone cancer	0.000627	0.0142	CcSEcCtD
Phenobarbital—Hypoxia—Methotrexate—bone cancer	0.000591	0.0134	CcSEcCtD
Phenobarbital—Hypothermia—Doxorubicin—bone cancer	0.00058	0.0132	CcSEcCtD
Phenobarbital—Body temperature decreased—Doxorubicin—bone cancer	0.00058	0.0132	CcSEcCtD
Phenobarbital—Nystagmus—Epirubicin—bone cancer	0.000492	0.0112	CcSEcCtD
Phenobarbital—Blister—Epirubicin—bone cancer	0.000488	0.0111	CcSEcCtD
Phenobarbital—Necrosis—Methotrexate—bone cancer	0.000478	0.0109	CcSEcCtD
Phenobarbital—Irritability—Cisplatin—bone cancer	0.000474	0.0108	CcSEcCtD
Phenobarbital—Nystagmus—Doxorubicin—bone cancer	0.000455	0.0103	CcSEcCtD
Phenobarbital—Blister—Doxorubicin—bone cancer	0.000451	0.0102	CcSEcCtD
Phenobarbital—Necrosis—Epirubicin—bone cancer	0.000448	0.0102	CcSEcCtD
Phenobarbital—Apnoea—Methotrexate—bone cancer	0.000443	0.0101	CcSEcCtD
Phenobarbital—Extravasation—Methotrexate—bone cancer	0.00043	0.00977	CcSEcCtD
Phenobarbital—Liver injury—Epirubicin—bone cancer	0.000418	0.00948	CcSEcCtD
Phenobarbital—Necrosis—Doxorubicin—bone cancer	0.000414	0.00941	CcSEcCtD
Phenobarbital—Delirium—Epirubicin—bone cancer	0.000409	0.00928	CcSEcCtD
Phenobarbital—Extravasation—Epirubicin—bone cancer	0.000403	0.00915	CcSEcCtD
Phenobarbital—Liver injury—Doxorubicin—bone cancer	0.000386	0.00877	CcSEcCtD
Phenobarbital—Thinking abnormal—Epirubicin—bone cancer	0.000384	0.00872	CcSEcCtD
Phenobarbital—Hypocalcaemia—Epirubicin—bone cancer	0.000384	0.00872	CcSEcCtD
Phenobarbital—Respiratory failure—Methotrexate—bone cancer	0.000382	0.00868	CcSEcCtD
Phenobarbital—Delirium—Doxorubicin—bone cancer	0.000378	0.00858	CcSEcCtD
Phenobarbital—Renal failure—Cisplatin—bone cancer	0.000376	0.00854	CcSEcCtD
Phenobarbital—Extravasation—Doxorubicin—bone cancer	0.000373	0.00846	CcSEcCtD
Phenobarbital—Depressed level of consciousness—Methotrexate—bone cancer	0.000363	0.00823	CcSEcCtD
Phenobarbital—Thinking abnormal—Doxorubicin—bone cancer	0.000355	0.00806	CcSEcCtD
Phenobarbital—Hypocalcaemia—Doxorubicin—bone cancer	0.000355	0.00806	CcSEcCtD
Phenobarbital—Hepatocellular injury—Epirubicin—bone cancer	0.000351	0.00798	CcSEcCtD
Phenobarbital—Bradycardia—Cisplatin—bone cancer	0.00035	0.00794	CcSEcCtD
Phenobarbital—Injection site reaction—Epirubicin—bone cancer	0.000349	0.00793	CcSEcCtD
Phenobarbital—Coma—Methotrexate—bone cancer	0.000343	0.00779	CcSEcCtD
Phenobarbital—Hepatocellular injury—Doxorubicin—bone cancer	0.000325	0.00738	CcSEcCtD
Phenobarbital—Injection site reaction—Doxorubicin—bone cancer	0.000323	0.00734	CcSEcCtD
Phenobarbital—Coma—Epirubicin—bone cancer	0.000321	0.00729	CcSEcCtD
Phenobarbital—Mental disability—Epirubicin—bone cancer	0.000305	0.00692	CcSEcCtD
Phenobarbital—Erythema—Cisplatin—bone cancer	0.000299	0.00679	CcSEcCtD
Phenobarbital—Coma—Doxorubicin—bone cancer	0.000297	0.00675	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Methotrexate—bone cancer	0.000289	0.00656	CcSEcCtD
Phenobarbital—Mental disability—Doxorubicin—bone cancer	0.000282	0.00641	CcSEcCtD
Phenobarbital—Lethargy—Methotrexate—bone cancer	0.000278	0.00632	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Epirubicin—bone cancer	0.00027	0.00614	CcSEcCtD
Phenobarbital—Dermatitis bullous—Epirubicin—bone cancer	0.000267	0.00606	CcSEcCtD
Phenobarbital—Lethargy—Epirubicin—bone cancer	0.00026	0.00591	CcSEcCtD
Phenobarbital—Irritability—Methotrexate—bone cancer	0.00026	0.00591	CcSEcCtD
Phenobarbital—Mood swings—Methotrexate—bone cancer	0.000258	0.00586	CcSEcCtD
Phenobarbital—Ataxia—Methotrexate—bone cancer	0.000256	0.00582	CcSEcCtD
Phenobarbital—Myalgia—Cisplatin—bone cancer	0.000255	0.00578	CcSEcCtD
Phenobarbital—Anxiety—Cisplatin—bone cancer	0.000254	0.00576	CcSEcCtD
Phenobarbital—Affect lability—Epirubicin—bone cancer	0.000251	0.0057	CcSEcCtD
Phenobarbital—Dermatitis exfoliative—Doxorubicin—bone cancer	0.00025	0.00568	CcSEcCtD
Phenobarbital—Dermatitis bullous—Doxorubicin—bone cancer	0.000247	0.00561	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000245	0.00557	CcSEcCtD
Phenobarbital—Mood swings—Epirubicin—bone cancer	0.000242	0.00549	CcSEcCtD
Phenobarbital—Lethargy—Doxorubicin—bone cancer	0.000241	0.00547	CcSEcCtD
Phenobarbital—Ataxia—Epirubicin—bone cancer	0.00024	0.00545	CcSEcCtD
Phenobarbital—Asthma—Methotrexate—bone cancer	0.000236	0.00535	CcSEcCtD
Phenobarbital—Affect lability—Doxorubicin—bone cancer	0.000232	0.00527	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00023	0.00522	CcSEcCtD
Phenobarbital—Hypotension—Cisplatin—bone cancer	0.000228	0.00518	CcSEcCtD
Phenobarbital—Mood swings—Doxorubicin—bone cancer	0.000224	0.00508	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000222	0.00505	CcSEcCtD
Phenobarbital—Ataxia—Doxorubicin—bone cancer	0.000222	0.00504	CcSEcCtD
Phenobarbital—Asthma—Epirubicin—bone cancer	0.00022	0.00501	CcSEcCtD
Phenobarbital—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000213	0.00483	CcSEcCtD
Phenobarbital—Drowsiness—Methotrexate—bone cancer	0.00021	0.00477	CcSEcCtD
Phenobarbital—Pain—Cisplatin—bone cancer	0.000209	0.00474	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000208	0.00473	CcSEcCtD
Phenobarbital—Renal failure—Methotrexate—bone cancer	0.000206	0.00469	CcSEcCtD
Phenobarbital—Asthma—Doxorubicin—bone cancer	0.000204	0.00463	CcSEcCtD
Phenobarbital—Feeling abnormal—Cisplatin—bone cancer	0.000201	0.00457	CcSEcCtD
Phenobarbital—Drowsiness—Epirubicin—bone cancer	0.000197	0.00446	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000195	0.00443	CcSEcCtD
Phenobarbital—Renal failure—Epirubicin—bone cancer	0.000193	0.00439	CcSEcCtD
Phenobarbital—Body temperature increased—Cisplatin—bone cancer	0.000193	0.00438	CcSEcCtD
Phenobarbital—Hepatitis—Methotrexate—bone cancer	0.000189	0.00428	CcSEcCtD
Phenobarbital—Drowsiness—Doxorubicin—bone cancer	0.000182	0.00413	CcSEcCtD
Phenobarbital—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00018	0.00409	CcSEcCtD
Phenobarbital—Hypersensitivity—Cisplatin—bone cancer	0.00018	0.00408	CcSEcCtD
Phenobarbital—Bradycardia—Epirubicin—bone cancer	0.00018	0.00408	CcSEcCtD
Phenobarbital—Renal failure—Doxorubicin—bone cancer	0.000179	0.00406	CcSEcCtD
Phenobarbital—Erythema multiforme—Methotrexate—bone cancer	0.000178	0.00405	CcSEcCtD
Phenobarbital—Hepatitis—Epirubicin—bone cancer	0.000176	0.00401	CcSEcCtD
Phenobarbital—Erythema multiforme—Epirubicin—bone cancer	0.000167	0.00379	CcSEcCtD
Phenobarbital—Bradycardia—Doxorubicin—bone cancer	0.000166	0.00377	CcSEcCtD
Phenobarbital—Erythema—Methotrexate—bone cancer	0.000164	0.00373	CcSEcCtD
Phenobarbital—Hepatitis—Doxorubicin—bone cancer	0.000163	0.00371	CcSEcCtD
Phenobarbital—Vomiting—Cisplatin—bone cancer	0.000155	0.00352	CcSEcCtD
Phenobarbital—Erythema multiforme—Doxorubicin—bone cancer	0.000154	0.00351	CcSEcCtD
Phenobarbital—Rash—Cisplatin—bone cancer	0.000154	0.0035	CcSEcCtD
Phenobarbital—Dermatitis—Cisplatin—bone cancer	0.000154	0.00349	CcSEcCtD
Phenobarbital—Erythema—Epirubicin—bone cancer	0.000154	0.00349	CcSEcCtD
Phenobarbital—Tension—Epirubicin—bone cancer	0.000151	0.00342	CcSEcCtD
Phenobarbital—Nervousness—Epirubicin—bone cancer	0.000149	0.00339	CcSEcCtD
Phenobarbital—Vertigo—Methotrexate—bone cancer	0.000147	0.00335	CcSEcCtD
Phenobarbital—Nausea—Cisplatin—bone cancer	0.000145	0.00329	CcSEcCtD
Phenobarbital—Erythema—Doxorubicin—bone cancer	0.000142	0.00323	CcSEcCtD
Phenobarbital—Agitation—Epirubicin—bone cancer	0.000141	0.00321	CcSEcCtD
Phenobarbital—Arthralgia—Methotrexate—bone cancer	0.00014	0.00317	CcSEcCtD
Phenobarbital—Myalgia—Methotrexate—bone cancer	0.00014	0.00317	CcSEcCtD
Phenobarbital—Tension—Doxorubicin—bone cancer	0.000139	0.00317	CcSEcCtD
Phenobarbital—Nervousness—Doxorubicin—bone cancer	0.000138	0.00313	CcSEcCtD
Phenobarbital—Vertigo—Epirubicin—bone cancer	0.000138	0.00313	CcSEcCtD
Phenobarbital—Syncope—Epirubicin—bone cancer	0.000138	0.00313	CcSEcCtD
Phenobarbital—Confusional state—Methotrexate—bone cancer	0.000135	0.00307	CcSEcCtD
Phenobarbital—Loss of consciousness—Epirubicin—bone cancer	0.000135	0.00307	CcSEcCtD
Phenobarbital—Arthralgia—Epirubicin—bone cancer	0.000131	0.00297	CcSEcCtD
Phenobarbital—Myalgia—Epirubicin—bone cancer	0.000131	0.00297	CcSEcCtD
Phenobarbital—Agitation—Doxorubicin—bone cancer	0.000131	0.00297	CcSEcCtD
Phenobarbital—Anxiety—Epirubicin—bone cancer	0.00013	0.00296	CcSEcCtD
Phenobarbital—Vertigo—Doxorubicin—bone cancer	0.000128	0.0029	CcSEcCtD
Phenobarbital—Syncope—Doxorubicin—bone cancer	0.000127	0.00289	CcSEcCtD
Phenobarbital—Confusional state—Epirubicin—bone cancer	0.000126	0.00287	CcSEcCtD
Phenobarbital—Hypotension—Methotrexate—bone cancer	0.000125	0.00284	CcSEcCtD
Phenobarbital—Loss of consciousness—Doxorubicin—bone cancer	0.000125	0.00284	CcSEcCtD
Phenobarbital—Shock—Epirubicin—bone cancer	0.000123	0.0028	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000122	0.00277	CcSEcCtD
Phenobarbital—Arthralgia—Doxorubicin—bone cancer	0.000121	0.00275	CcSEcCtD
Phenobarbital—Myalgia—Doxorubicin—bone cancer	0.000121	0.00275	CcSEcCtD
Phenobarbital—Anxiety—Doxorubicin—bone cancer	0.000121	0.00274	CcSEcCtD
Phenobarbital—Somnolence—Methotrexate—bone cancer	0.000119	0.0027	CcSEcCtD
Phenobarbital—Hypotension—Epirubicin—bone cancer	0.000117	0.00266	CcSEcCtD
Phenobarbital—Confusional state—Doxorubicin—bone cancer	0.000117	0.00266	CcSEcCtD
Phenobarbital—Pain—Methotrexate—bone cancer	0.000115	0.0026	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000114	0.00259	CcSEcCtD
Phenobarbital—Shock—Doxorubicin—bone cancer	0.000114	0.00259	CcSEcCtD
Phenobarbital—Somnolence—Epirubicin—bone cancer	0.000111	0.00253	CcSEcCtD
Phenobarbital—Feeling abnormal—Methotrexate—bone cancer	0.00011	0.00251	CcSEcCtD
Phenobarbital—Hypotension—Doxorubicin—bone cancer	0.000108	0.00246	CcSEcCtD
Phenobarbital—Pain—Epirubicin—bone cancer	0.000107	0.00243	CcSEcCtD
Phenobarbital—Constipation—Epirubicin—bone cancer	0.000107	0.00243	CcSEcCtD
Phenobarbital—Urticaria—Methotrexate—bone cancer	0.000106	0.00242	CcSEcCtD
Phenobarbital—Body temperature increased—Methotrexate—bone cancer	0.000106	0.0024	CcSEcCtD
Phenobarbital—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000106	0.0024	CcSEcCtD
Phenobarbital—Feeling abnormal—Epirubicin—bone cancer	0.000103	0.00235	CcSEcCtD
Phenobarbital—Somnolence—Doxorubicin—bone cancer	0.000103	0.00234	CcSEcCtD
Phenobarbital—Urticaria—Epirubicin—bone cancer	9.96e-05	0.00226	CcSEcCtD
Phenobarbital—Pain—Doxorubicin—bone cancer	9.92e-05	0.00225	CcSEcCtD
Phenobarbital—Constipation—Doxorubicin—bone cancer	9.92e-05	0.00225	CcSEcCtD
Phenobarbital—Body temperature increased—Epirubicin—bone cancer	9.91e-05	0.00225	CcSEcCtD
Phenobarbital—Hypersensitivity—Methotrexate—bone cancer	9.87e-05	0.00224	CcSEcCtD
Phenobarbital—Feeling abnormal—Doxorubicin—bone cancer	9.56e-05	0.00217	CcSEcCtD
Phenobarbital—Hypersensitivity—Epirubicin—bone cancer	9.24e-05	0.0021	CcSEcCtD
Phenobarbital—Urticaria—Doxorubicin—bone cancer	9.22e-05	0.00209	CcSEcCtD
Phenobarbital—Body temperature increased—Doxorubicin—bone cancer	9.17e-05	0.00208	CcSEcCtD
Phenobarbital—Dizziness—Methotrexate—bone cancer	8.86e-05	0.00201	CcSEcCtD
Phenobarbital—Primidone—CYP3A4—bone cancer	8.74e-05	0.4	CrCbGaD
Phenobarbital—Hypersensitivity—Doxorubicin—bone cancer	8.55e-05	0.00194	CcSEcCtD
Phenobarbital—Vomiting—Methotrexate—bone cancer	8.52e-05	0.00193	CcSEcCtD
Phenobarbital—Rash—Methotrexate—bone cancer	8.45e-05	0.00192	CcSEcCtD
Phenobarbital—Dermatitis—Methotrexate—bone cancer	8.44e-05	0.00192	CcSEcCtD
Phenobarbital—Headache—Methotrexate—bone cancer	8.39e-05	0.00191	CcSEcCtD
Phenobarbital—Dizziness—Epirubicin—bone cancer	8.29e-05	0.00188	CcSEcCtD
Phenobarbital—Vomiting—Epirubicin—bone cancer	7.97e-05	0.00181	CcSEcCtD
Phenobarbital—Nausea—Methotrexate—bone cancer	7.96e-05	0.00181	CcSEcCtD
Phenobarbital—Rash—Epirubicin—bone cancer	7.9e-05	0.00179	CcSEcCtD
Phenobarbital—Dermatitis—Epirubicin—bone cancer	7.9e-05	0.00179	CcSEcCtD
Phenobarbital—Headache—Epirubicin—bone cancer	7.85e-05	0.00178	CcSEcCtD
Phenobarbital—Dizziness—Doxorubicin—bone cancer	7.67e-05	0.00174	CcSEcCtD
Phenobarbital—Nausea—Epirubicin—bone cancer	7.45e-05	0.00169	CcSEcCtD
Phenobarbital—Vomiting—Doxorubicin—bone cancer	7.38e-05	0.00167	CcSEcCtD
Phenobarbital—Pentobarbital—CYP3A4—bone cancer	7.36e-05	0.337	CrCbGaD
Phenobarbital—Rash—Doxorubicin—bone cancer	7.31e-05	0.00166	CcSEcCtD
Phenobarbital—Dermatitis—Doxorubicin—bone cancer	7.31e-05	0.00166	CcSEcCtD
Phenobarbital—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	7.28e-05	0.00071	CbGpPWpGaD
Phenobarbital—Headache—Doxorubicin—bone cancer	7.27e-05	0.00165	CcSEcCtD
Phenobarbital—CYP1A1—Arachidonic acid metabolism—PTGS2—bone cancer	7.22e-05	0.000705	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—BRAF—bone cancer	7.13e-05	0.000696	CbGpPWpGaD
Phenobarbital—CYP2A6—Biological oxidations—GSTP1—bone cancer	6.96e-05	0.000679	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.96e-05	0.000679	CbGpPWpGaD
Phenobarbital—Nausea—Doxorubicin—bone cancer	6.89e-05	0.00156	CcSEcCtD
Phenobarbital—ABCC2—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.82e-05	0.000665	CbGpPWpGaD
Phenobarbital—ABCC1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.74e-05	0.000658	CbGpPWpGaD
Phenobarbital—CHRNA4—SIDS Susceptibility Pathways—JUN—bone cancer	6.74e-05	0.000658	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—NT5C3A—bone cancer	6.73e-05	0.000657	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—NT5C3A—bone cancer	6.63e-05	0.000647	CbGpPWpGaD
Phenobarbital—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	6.62e-05	0.000646	CbGpPWpGaD
Phenobarbital—CYP2B6—Biological oxidations—CYP3A4—bone cancer	6.57e-05	0.000641	CbGpPWpGaD
Phenobarbital—GRIK2—Neuronal System—MDM2—bone cancer	6.56e-05	0.000641	CbGpPWpGaD
Phenobarbital—GRIA2—Transmission across Chemical Synapses—MDM2—bone cancer	6.55e-05	0.000639	CbGpPWpGaD
Phenobarbital—CYP2B6—Metapathway biotransformation—CYP3A4—bone cancer	6.47e-05	0.000632	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—NT5C3A—bone cancer	6.45e-05	0.00063	CbGpPWpGaD
Phenobarbital—CYP2E1—Biological oxidations—CYP3A4—bone cancer	6.43e-05	0.000628	CbGpPWpGaD
Phenobarbital—CYP3A5—Biological oxidations—CYP3A4—bone cancer	6.42e-05	0.000626	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—ENO2—bone cancer	6.39e-05	0.000624	CbGpPWpGaD
Phenobarbital—GABRA1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.39e-05	0.000624	CbGpPWpGaD
Phenobarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—bone cancer	6.35e-05	0.00062	CbGpPWpGaD
Phenobarbital—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	6.34e-05	0.000619	CbGpPWpGaD
Phenobarbital—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	6.33e-05	0.000618	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	6.32e-05	0.000617	CbGpPWpGaD
Phenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	6.24e-05	0.00061	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—NDUFA12—bone cancer	6.1e-05	0.000596	CbGpPWpGaD
Phenobarbital—CYP1A1—Biological oxidations—CYP3A4—bone cancer	6.06e-05	0.000592	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—BRAF—bone cancer	5.99e-05	0.000585	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	5.99e-05	0.000584	CbGpPWpGaD
Phenobarbital—CYP1A1—Metapathway biotransformation—CYP3A4—bone cancer	5.98e-05	0.000584	CbGpPWpGaD
Phenobarbital—CHRNA7—Neuronal System—MDM2—bone cancer	5.97e-05	0.000583	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—DHFR—bone cancer	5.93e-05	0.000579	CbGpPWpGaD
Phenobarbital—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	5.91e-05	0.000577	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—NDUFA12—bone cancer	5.9e-05	0.000576	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—BRAF—bone cancer	5.81e-05	0.000567	CbGpPWpGaD
Phenobarbital—Phenytoin—CYP3A4—bone cancer	5.75e-05	0.263	CrCbGaD
Phenobarbital—CYP1A2—Phase II conjugation—GSTP1—bone cancer	5.65e-05	0.000552	CbGpPWpGaD
Phenobarbital—CYP2B6—Biological oxidations—GSTP1—bone cancer	5.61e-05	0.000548	CbGpPWpGaD
Phenobarbital—CYP2C8—Biological oxidations—CYP3A4—bone cancer	5.56e-05	0.000543	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—GNA11—bone cancer	5.54e-05	0.000541	CbGpPWpGaD
Phenobarbital—CYP2B6—Metapathway biotransformation—GSTP1—bone cancer	5.54e-05	0.000541	CbGpPWpGaD
Phenobarbital—CYP2E1—Biological oxidations—GSTP1—bone cancer	5.5e-05	0.000537	CbGpPWpGaD
Phenobarbital—CYP3A5—Biological oxidations—GSTP1—bone cancer	5.49e-05	0.000536	CbGpPWpGaD
Phenobarbital—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	5.48e-05	0.000535	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.47e-05	0.000534	CbGpPWpGaD
Phenobarbital—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.47e-05	0.000534	CbGpPWpGaD
Phenobarbital—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	5.42e-05	0.000529	CbGpPWpGaD
Phenobarbital—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	5.41e-05	0.000528	CbGpPWpGaD
Phenobarbital—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	5.39e-05	0.000526	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	5.37e-05	0.000524	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—NDUFA12—bone cancer	5.32e-05	0.000519	CbGpPWpGaD
Phenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	5.23e-05	0.000511	CbGpPWpGaD
Phenobarbital—CYP1A1—Biological oxidations—GSTP1—bone cancer	5.19e-05	0.000506	CbGpPWpGaD
Phenobarbital—CYP1A1—Metapathway biotransformation—GSTP1—bone cancer	5.11e-05	0.000499	CbGpPWpGaD
Phenobarbital—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	5.1e-05	0.000498	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—NT5C3A—bone cancer	5.06e-05	0.000494	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—CYP3A4—bone cancer	5.02e-05	0.00049	CbGpPWpGaD
Phenobarbital—GRIA2—Neuronal System—MDM2—bone cancer	5.02e-05	0.00049	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	5e-05	0.000488	CbGpPWpGaD
Phenobarbital—CYP2C19—Biological oxidations—CYP3A4—bone cancer	4.96e-05	0.000484	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	4.92e-05	0.00048	CbGpPWpGaD
Phenobarbital—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	4.89e-05	0.000478	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	4.89e-05	0.000477	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—NT5C3A—bone cancer	4.89e-05	0.000477	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—NDUFA12—bone cancer	4.88e-05	0.000476	CbGpPWpGaD
Phenobarbital—CHRNA4—Neuronal System—MDM2—bone cancer	4.87e-05	0.000475	CbGpPWpGaD
Phenobarbital—CYP2C8—Biological oxidations—GSTP1—bone cancer	4.75e-05	0.000464	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—BRAF—bone cancer	4.69e-05	0.000458	CbGpPWpGaD
Phenobarbital—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	4.69e-05	0.000458	CbGpPWpGaD
Phenobarbital—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	4.6e-05	0.000449	CbGpPWpGaD
Phenobarbital—CYP2C9—Biological oxidations—CYP3A4—bone cancer	4.52e-05	0.000442	CbGpPWpGaD
Phenobarbital—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	4.46e-05	0.000436	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	4.45e-05	0.000435	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	4.44e-05	0.000433	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—NT5C3A—bone cancer	4.41e-05	0.00043	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	4.39e-05	0.000429	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—GSTP1—bone cancer	4.3e-05	0.000419	CbGpPWpGaD
Phenobarbital—CYP2C19—Biological oxidations—GSTP1—bone cancer	4.24e-05	0.000414	CbGpPWpGaD
Phenobarbital—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	4.18e-05	0.000409	CbGpPWpGaD
Phenobarbital—GABRA1—SIDS Susceptibility Pathways—JUN—bone cancer	4.17e-05	0.000407	CbGpPWpGaD
Phenobarbital—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	4.16e-05	0.000406	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—NT5C3A—bone cancer	4.04e-05	0.000395	CbGpPWpGaD
Phenobarbital—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	3.94e-05	0.000384	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NDUFA12—bone cancer	3.94e-05	0.000384	CbGpPWpGaD
Phenobarbital—GABRA1—Transmission across Chemical Synapses—MDM2—bone cancer	3.93e-05	0.000384	CbGpPWpGaD
Phenobarbital—CYP2C9—Biological oxidations—GSTP1—bone cancer	3.87e-05	0.000378	CbGpPWpGaD
Phenobarbital—CYP1A2—Biological oxidations—CYP3A4—bone cancer	3.87e-05	0.000377	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NDUFA12—bone cancer	3.85e-05	0.000376	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NDUFA12—bone cancer	3.85e-05	0.000375	CbGpPWpGaD
Phenobarbital—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	3.82e-05	0.000372	CbGpPWpGaD
Phenobarbital—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	3.81e-05	0.000372	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	3.72e-05	0.000363	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	3.71e-05	0.000362	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NDUFA12—bone cancer	3.63e-05	0.000355	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—BRAF—bone cancer	3.6e-05	0.000351	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	3.49e-05	0.00034	CbGpPWpGaD
Phenobarbital—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	3.49e-05	0.00034	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NDUFA12—bone cancer	3.33e-05	0.000325	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—ENO2—bone cancer	3.32e-05	0.000324	CbGpPWpGaD
Phenobarbital—CYP1A2—Biological oxidations—GSTP1—bone cancer	3.31e-05	0.000323	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—NT5C3A—bone cancer	3.26e-05	0.000318	CbGpPWpGaD
Phenobarbital—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	3.26e-05	0.000318	CbGpPWpGaD
Phenobarbital—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	3.2e-05	0.000313	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—NT5C3A—bone cancer	3.19e-05	0.000312	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—NT5C3A—bone cancer	3.19e-05	0.000311	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—DHFR—bone cancer	3.08e-05	0.000301	CbGpPWpGaD
Phenobarbital—GABRA1—Neuronal System—MDM2—bone cancer	3.01e-05	0.000294	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—NT5C3A—bone cancer	3.01e-05	0.000294	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NDUFA12—bone cancer	2.97e-05	0.00029	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—ENO2—bone cancer	2.95e-05	0.000288	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—ENO2—bone cancer	2.91e-05	0.000284	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NDUFA12—bone cancer	2.9e-05	0.000283	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—GNA11—bone cancer	2.88e-05	0.000281	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—ENO2—bone cancer	2.83e-05	0.000276	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	2.76e-05	0.000269	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—NT5C3A—bone cancer	2.76e-05	0.000269	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—DHFR—bone cancer	2.73e-05	0.000267	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NDUFA12—bone cancer	2.71e-05	0.000265	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—DHFR—bone cancer	2.7e-05	0.000263	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—ENO2—bone cancer	2.64e-05	0.000258	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—DHFR—bone cancer	2.62e-05	0.000256	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—CYP3A4—bone cancer	2.61e-05	0.000255	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.6e-05	0.000254	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—GNA11—bone cancer	2.56e-05	0.000249	CbGpPWpGaD
Phenobarbital—CYP3A4—Biological oxidations—GSTP1—bone cancer	2.55e-05	0.000249	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—GNA11—bone cancer	2.52e-05	0.000246	CbGpPWpGaD
Phenobarbital—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	2.52e-05	0.000246	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—NT5C3A—bone cancer	2.46e-05	0.000241	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—DHFR—bone cancer	2.45e-05	0.000239	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—GNA11—bone cancer	2.45e-05	0.000239	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—NT5C3A—bone cancer	2.41e-05	0.000235	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NDUFA12—bone cancer	2.32e-05	0.000226	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—CYP3A4—bone cancer	2.32e-05	0.000226	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.31e-05	0.000225	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—CYP3A4—bone cancer	2.28e-05	0.000223	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—NT5C3A—bone cancer	2.25e-05	0.000219	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—GSTP1—bone cancer	2.23e-05	0.000218	CbGpPWpGaD
Phenobarbital—CYP4B1—Metabolism—PTGS2—bone cancer	2.23e-05	0.000217	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—CYP3A4—bone cancer	2.22e-05	0.000217	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—ENO2—bone cancer	2.21e-05	0.000216	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.21e-05	0.000216	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—ENO2—bone cancer	2.14e-05	0.000209	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—DHFR—bone cancer	2.05e-05	0.000201	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	2.05e-05	0.0002	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—DHFR—bone cancer	1.99e-05	0.000194	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—GSTP1—bone cancer	1.98e-05	0.000193	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	1.97e-05	0.000193	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—GSTP1—bone cancer	1.95e-05	0.000191	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—ENO2—bone cancer	1.93e-05	0.000189	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—GNA11—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—NT5C3A—bone cancer	1.92e-05	0.000187	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—GSTP1—bone cancer	1.9e-05	0.000185	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—GNA11—bone cancer	1.86e-05	0.000181	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—DHFR—bone cancer	1.79e-05	0.000175	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NDUFA12—bone cancer	1.79e-05	0.000175	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	1.78e-05	0.000174	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—TGFBR2—bone cancer	1.78e-05	0.000174	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—ENO2—bone cancer	1.77e-05	0.000173	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—CYP3A4—bone cancer	1.74e-05	0.00017	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	0.000169	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—CYP3A4—bone cancer	1.68e-05	0.000164	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.67e-05	0.000164	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GNA11—bone cancer	1.67e-05	0.000163	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—DHFR—bone cancer	1.64e-05	0.00016	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GNA11—bone cancer	1.53e-05	0.00015	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—CYP3A4—bone cancer	1.52e-05	0.000148	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—GSTP1—bone cancer	1.49e-05	0.000145	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—NT5C3A—bone cancer	1.48e-05	0.000145	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—GSTP1—bone cancer	1.44e-05	0.000141	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—ENO2—bone cancer	1.43e-05	0.000139	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—ENO2—bone cancer	1.4e-05	0.000137	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	1.4e-05	0.000137	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—ENO2—bone cancer	1.4e-05	0.000136	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—CYP3A4—bone cancer	1.39e-05	0.000136	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—DHFR—bone cancer	1.33e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—ENO2—bone cancer	1.32e-05	0.000129	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—GSTP1—bone cancer	1.3e-05	0.000127	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—DHFR—bone cancer	1.3e-05	0.000127	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—DHFR—bone cancer	1.3e-05	0.000126	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GNA11—bone cancer	1.24e-05	0.000121	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—DHFR—bone cancer	1.22e-05	0.000119	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—KIT—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GNA11—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GNA11—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—ENO2—bone cancer	1.21e-05	0.000118	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—GSTP1—bone cancer	1.19e-05	0.000116	CbGpPWpGaD
Phenobarbital—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	1.17e-05	0.000115	CbGpPWpGaD
Phenobarbital—CYP4A11—Metabolism—PTGS2—bone cancer	1.16e-05	0.000113	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GNA11—bone cancer	1.14e-05	0.000112	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—BRAF—bone cancer	1.14e-05	0.000111	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—CYP3A4—bone cancer	1.12e-05	0.00011	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—DHFR—bone cancer	1.12e-05	0.00011	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000107	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—CYP3A4—bone cancer	1.1e-05	0.000107	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—ENO2—bone cancer	1.08e-05	0.000105	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—ENO2—bone cancer	1.05e-05	0.000103	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GNA11—bone cancer	1.05e-05	0.000102	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—CYP3A4—bone cancer	1.04e-05	0.000101	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.03e-05	0.000101	CbGpPWpGaD
Phenobarbital—ABCB11—Metabolism—PTGS2—bone cancer	1.03e-05	0.0001	CbGpPWpGaD
Phenobarbital—CYP2C18—Metabolism—PTGS2—bone cancer	1.01e-05	9.88e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—DHFR—bone cancer	1e-05	9.77e-05	CbGpPWpGaD
Phenobarbital—ABCC3—Metabolism—PTGS2—bone cancer	9.84e-06	9.61e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—ENO2—bone cancer	9.84e-06	9.61e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—DHFR—bone cancer	9.77e-06	9.54e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—GSTP1—bone cancer	9.6e-06	9.37e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—MDM2—bone cancer	9.55e-06	9.33e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—CYP3A4—bone cancer	9.51e-06	9.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.46e-06	9.23e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—GSTP1—bone cancer	9.41e-06	9.18e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—GSTP1—bone cancer	9.39e-06	9.16e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GNA11—bone cancer	9.36e-06	9.14e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—PTGS2—bone cancer	9.21e-06	8.99e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GNA11—bone cancer	9.13e-06	8.92e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—DHFR—bone cancer	9.13e-06	8.91e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—GSTP1—bone cancer	8.87e-06	8.66e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GNA11—bone cancer	8.53e-06	8.33e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—CYP3A4—bone cancer	8.48e-06	8.28e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	8.44e-06	8.24e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—ENO2—bone cancer	8.41e-06	8.21e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—CYP3A4—bone cancer	8.28e-06	8.08e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—GSTP1—bone cancer	8.13e-06	7.94e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—DHFR—bone cancer	7.8e-06	7.62e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—CYP3A4—bone cancer	7.74e-06	7.55e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Metabolism—PTGS2—bone cancer	7.71e-06	7.53e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	7.7e-06	7.51e-05	CbGpPWpGaD
Phenobarbital—CYP1B1—Metabolism—PTGS2—bone cancer	7.46e-06	7.28e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GNA11—bone cancer	7.29e-06	7.12e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—GSTP1—bone cancer	7.26e-06	7.08e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—GSTP1—bone cancer	7.08e-06	6.91e-05	CbGpPWpGaD
Phenobarbital—CYP3A7—Metabolism—PTGS2—bone cancer	6.73e-06	6.57e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—GSTP1—bone cancer	6.62e-06	6.46e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—CYP3A4—bone cancer	6.61e-06	6.45e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.58e-06	6.42e-05	CbGpPWpGaD
Phenobarbital—ABCC1—Disease—EGFR—bone cancer	6.53e-06	6.37e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—ENO2—bone cancer	6.49e-06	6.34e-05	CbGpPWpGaD
Phenobarbital—CYP2A6—Metabolism—PTGS2—bone cancer	6.17e-06	6.02e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—DHFR—bone cancer	6.02e-06	5.88e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—GSTP1—bone cancer	5.65e-06	5.52e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GNA11—bone cancer	5.63e-06	5.49e-05	CbGpPWpGaD
Phenobarbital—CYP2B6—Metabolism—PTGS2—bone cancer	4.97e-06	4.86e-05	CbGpPWpGaD
Phenobarbital—CYP2E1—Metabolism—PTGS2—bone cancer	4.87e-06	4.76e-05	CbGpPWpGaD
Phenobarbital—CYP3A5—Metabolism—PTGS2—bone cancer	4.86e-06	4.75e-05	CbGpPWpGaD
Phenobarbital—CYP1A1—Metabolism—PTGS2—bone cancer	4.59e-06	4.48e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—GSTP1—bone cancer	4.36e-06	4.26e-05	CbGpPWpGaD
Phenobarbital—CYP2C8—Metabolism—PTGS2—bone cancer	4.21e-06	4.11e-05	CbGpPWpGaD
Phenobarbital—CYP2C19—Metabolism—PTGS2—bone cancer	3.76e-06	3.67e-05	CbGpPWpGaD
Phenobarbital—ABCB1—Metabolism—PTGS2—bone cancer	3.67e-06	3.58e-05	CbGpPWpGaD
Phenobarbital—CYP2C9—Metabolism—PTGS2—bone cancer	3.43e-06	3.35e-05	CbGpPWpGaD
Phenobarbital—CYP1A2—Metabolism—PTGS2—bone cancer	2.93e-06	2.86e-05	CbGpPWpGaD
Phenobarbital—CYP3A4—Metabolism—PTGS2—bone cancer	2.26e-06	2.21e-05	CbGpPWpGaD
